$1.61
-0.05-3.01%
Last update: Nov 5, 9:23 AM
Pyxis Oncology Inc
PYXSNASDAQ
The average analyst price target for Pyxis Oncology is $8.80, 430.1% above the current price. Of 11 analysts, 10 rate it Buy and 1 Hold. Targets range from $5 to $19. The latest change came on Sep 10, 2026, when Wedbush raised its price target on Pyxis Oncology from $6 to $8 and kept an Outperform rating.
Price Target Range — 12 Quarters
Analyst Consensus — 11 Analysts
Rating Trend — Last 9 Months
